Aadi bioscience announces poster presentations at 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics

Los angeles , sept. 20, 2023 /prnewswire/ -- aadi bioscience, inc. (nasdaq: aadi), a biopharmaceutical company focused on developing and commercializing precision therapies for patients with mtor pathway alterations, today announced that four abstracts have been selected for presentation at the upcoming 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics, taking place october 11-15, 2023 in boston, ma.
AADI Ratings Summary
AADI Quant Ranking